
BUDEPRESS 0.5MG RESPULES 2ML 5'S
By STERIS HEALTHCARE PRIVATE LIMITED
Contains: BUDESONIDE 500 MCG /2ML

Product Summary
Offer Price | ₹ 16 |
---|---|
Your Savings | ₹ 7.55 (32% on MRP) |
About BUDEPRESS 0.5MG RESPULES 2ML 5'S
- Asthma and COPD symptoms are treated with the help of this medicine. It belongs to a drug class called "glucocorticosteroids." Additionally, it's used to treat autoimmune hepatitis, microscopic colitis, and chronic inflammatory illnesses of the liver and intestine like crohn's disease (inflammatory bowel disease). Mild to moderate ulcerative colitis may also be treated with it.
Benefits of BUDEPRESS 0.5MG RESPULES 2ML 5'S
- By lowering edema and irritation in the airways, it makes it easy to breathe.,It is used to treat a variety of respiratory conditions, including asthmatic chest tightness, wheezing, and coughing, allergic rhinitis (allergy that causes itchy, watery eyes, and sneezing), COPD (chronic obstructive pulmonary disease), and allergic rhinitis.
Frequently asked questions about BUDEPRESS 0.5MG RESPULES 2ML 5'S
It reduces irritation and inflammation in airways and makes breathing easier. Therefore, it relieves the symptoms of asthma and COPD.
It can make bones brittle, lose bone mass, and reduce bone density after long-term use. Tell your doctor if you have bone problems before you start taking this tablet.
It is used to treat mild to moderate Crohn's disease. However, it may not be suitable for patients with Crohn's disease, which affects the upper gastrointestinal tract.
Ronak Ankola
Reviewed on 25 Jul 2023
Ronak Ankola
Reviewed on 25 Jul 2023
Should display more medical verities.
Sunita Sain
Reviewed on 30 Nov 2022
Sunita Sain
Reviewed on 30 Nov 2022
Best Medical .... Low price... Best Company's...... Good nature.....
nitin kanwe
Reviewed on 09 Jul 2023
nitin kanwe
Reviewed on 09 Jul 2023
Generic medicines available at low cost
Parth Patil
Reviewed on 27 Jul 2023
Parth Patil
Reviewed on 27 Jul 2023
Good service, cheaper medicine and better quality and effective.
Dhara Patva
Reviewed on 10 Feb 2024
Dhara Patva
Reviewed on 10 Feb 2024
Good